These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31563157)

  • 1. An overview of the adverse effects of cannabis use for Canadian physicians.
    Leduc-Pessah H; Jensen SK; Newell C
    Clin Invest Med; 2019 Sep; 42(3):E17-E34. PubMed ID: 31563157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive and Negative Effects of Cannabis and Cannabinoids on Health.
    Cohen K; Weizman A; Weinstein A
    Clin Pharmacol Ther; 2019 May; 105(5):1139-1147. PubMed ID: 30703255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis and neuropsychiatry, 1: benefits and risks.
    Andrade C
    J Clin Psychiatry; 2016 May; 77(5):e551-4. PubMed ID: 27249079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and long-term effects of cannabis use: a review.
    Karila L; Roux P; Rolland B; Benyamina A; Reynaud M; Aubin HJ; Lançon C
    Curr Pharm Des; 2014; 20(25):4112-8. PubMed ID: 24001294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical use of cannabis products: Lessons to be learned from Israel and Canada.
    Ablin J; Ste-Marie PA; Schäfer M; Häuser W; Fitzcharles MA
    Schmerz; 2016 Feb; 30(1):3-13. PubMed ID: 26767992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and correlates of non-medical only compared to self-defined medical and non-medical cannabis use, Canada, 2015.
    Rotermann M; Pagé MM
    Health Rep; 2018 Jul; 29(7):3-13. PubMed ID: 30020531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical marijuana patient counseling points for health care professionals based on trends in the medical uses, efficacy, and adverse effects of cannabis-based pharmaceutical drugs.
    Parmar JR; Forrest BD; Freeman RA
    Res Social Adm Pharm; 2016; 12(4):638-54. PubMed ID: 26443472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marijuana: a time-honored but untested treatment for epilepsy.
    McLachlan RS
    Can J Neurol Sci; 2015 Mar; 42(2):88-91. PubMed ID: 25715711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pros and Cons of Medical Cannabis use by People with Chronic Brain Disorders.
    Suryadevara U; Bruijnzeel DM; Nuthi M; Jagnarine DA; Tandon R; Bruijnzeel AW
    Curr Neuropharmacol; 2017; 15(6):800-814. PubMed ID: 27804883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is cannabis treatment for anxiety, mood, and related disorders ready for prime time?
    Turna J; Patterson B; Van Ameringen M
    Depress Anxiety; 2017 Nov; 34(11):1006-1017. PubMed ID: 28636769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlates of Self-Reported Medicinal Cannabis Use for Physical Health, Mental Health, and Sleep-Related Conditions in a Population-Based Survey of Canadian Youth.
    Wardell JD
    J Stud Alcohol Drugs; 2022 Jul; 83(4):528-536. PubMed ID: 35838430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescribing medical cannabis in Canada: Are we being too cautious?
    Lake S; Kerr T; Montaner J
    Can J Public Health; 2015 Apr; 106(5):e328-30. PubMed ID: 26451996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinician views on and ethics priorities for authorizing medical cannabis in the care of children and youth in Canada: a qualitative study.
    Gunning M; Rotenberg AD; Kelly LE; Crooks B; Oberoi S; Rapoport AL; Rassekh SR; Illes J
    CMAJ Open; 2022; 10(1):E196-E202. PubMed ID: 35292477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical use of cannabis: an addiction medicine perspective.
    Cook J; Lloyd-Jones DM; Ogden E; Bonomo Y
    Intern Med J; 2015 Jun; 45(6):677-80. PubMed ID: 26059881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse effects of cannabis.
    Prescrire Int; 2011 Jan; 20(112):18-23. PubMed ID: 21462790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mental health functioning and severity of cannabis withdrawal among medical cannabis users with chronic pain.
    Perron BE; Holt KR; Yeagley E; Ilgen M
    Drug Alcohol Depend; 2019 Jan; 194():401-409. PubMed ID: 30500688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Use of Marijuana: The Thin Line Between Good and Evil?
    Salazar J; Rojas M; Espinoza C
    Arch Med Res; 2018 Aug; 49(6):421-422. PubMed ID: 30595363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical cannabis: considerations for the anesthesiologist and pain physician.
    Beaulieu P; Boulanger A; Desroches J; Clark AJ
    Can J Anaesth; 2016 May; 63(5):608-24. PubMed ID: 26850063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
    Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M
    Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cannabis--Position Paper of the German Respiratory Society (DGP)].
    Kreuter M; Nowak D; Rüther T; Hoch E; Thomasius R; Vogelberg C; Brockstedt M; Hellmann A; Gohlke H; Jany B; Loddenkemper R
    Pneumologie; 2016 Feb; 70(2):87-97. PubMed ID: 26935046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.